Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Raggi

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.
Cancer Research|June 25, 2014
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, et al.
Journal of Hepatology|September 6, 2016
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophagesChiara Raggi, Margherita Correnti, Antonio Sica, et al.
Cancer Research|October 21, 2010
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinomaYun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Hepatology (Baltimore, Md.)|May 7, 2021
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.
Communications Biology|May 23, 2026
FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approachGiacomo Ducci, Giorgia Ciufolini, Gloria Campioni, et al.
The Lancet Regional Health. Europe|March 17, 2025
Mapping the landscape of biliary tract cancer in Europe: challenges and controversiesLorenza Rimassa, Shahid Khan, Bas Groot Koerkamp, et al.
Journal of Hepatology|January 23, 2021
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinomaChiara Raggi, Maria Letizia Taddei, Elena Sacco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2021
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinomaMargherita Correnti, Andrea Cappon, Mirella Pastore, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.
Cancer Research|June 25, 2014
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, et al.
Journal of Hepatology|September 6, 2016
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophagesChiara Raggi, Margherita Correnti, Antonio Sica, et al.
Cancer Research|October 21, 2010
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinomaYun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Hepatology (Baltimore, Md.)|May 7, 2021
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.
Communications Biology|May 23, 2026
FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approachGiacomo Ducci, Giorgia Ciufolini, Gloria Campioni, et al.
The Lancet Regional Health. Europe|March 17, 2025
Mapping the landscape of biliary tract cancer in Europe: challenges and controversiesLorenza Rimassa, Shahid Khan, Bas Groot Koerkamp, et al.
Journal of Hepatology|January 23, 2021
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinomaChiara Raggi, Maria Letizia Taddei, Elena Sacco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2021
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinomaMargherita Correnti, Andrea Cappon, Mirella Pastore, et al.
Pageof 6